Condition: Ulcerative Colitis · Ulcerative Colitis Chronic · Sponsor: Eli Lilly and Company
The main purpose of this study is to determine the safety and efficacy of eltrekibart and mirikizumab in adult participants with moderately to severely active ulcerative colitis (UC).
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| AZ Gastro Care - Chandler | Chandler, Arizona, United States | Not Yet Recruiting |
| Applied Research Center of Arkansas | Little Rock, Arkansas, United States | Recruiting |
| Preferred Research Partners | Little Rock, Arkansas, United States | Not Yet Recruiting |
| Erick Alayo Medical Corp/Gastro SB Clinic | Chula Vista, California, United States | Recruiting |
| Southern California GI and Liver Centers (SCLC) | Coronado, California, United States | Recruiting |
| Valley View Research | Garden Grove, California, United States | Recruiting |
| Om Research, LLC | Lancaster, California, United States | Recruiting |
| United Medical Doctors | Los Alamitos, California, United States | Recruiting |
| Clinnova Research | Orange, California, United States | Recruiting |
| Prospective Research Innovations | Rancho Cucamonga, California, United States | Recruiting |
| Clinical Trials Management Services, LLC | Thousand Oaks, California, United States | Recruiting |
| Om Research LLC | Victorville, California, United States | Recruiting |
+ 195 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06598943